NCT04262804 2023-08-22
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Zai Lab (Hong Kong), Ltd.
Phase 2 Unknown
Clinical Trials
4 trialsNCT04556292 2020-09-21
A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 2 Unknown
NCT04368442 2020-04-29
BRCAm
Samsung Medical Center
Unknown
NCT03086785 2018-01-17
Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Unknown